Makhambetov Yerbol, Maidan Aiman, Nurimanov Chingiz, Kaliyev Assylbek, Kunakbayev Baurzhan, Nurakay Nurtay, Dyussembayev Serik, Makhambetov Nursultan
National Centre for Neurosurgery, Department of Vascular and Functional Neurosurgery, Astana, Kazakhstan
Diagn Interv Radiol. 2025 Jul 8;31(4):366-371. doi: 10.4274/dir.2024.242903. Epub 2024 Oct 21.
The use of flow diverter (FD) stents is continually expanding. Aneurysms on arterial bifurcation typically have an undesirable anatomical form, are frequently wide-necked, and include one or more side-branch arteries. In recent years, the off-label use of flow diversion in treating intracranial aneurysms beyond the internal carotid artery has become increasingly popular. This study reports our center's initial experience treating bifurcation aneurysms with FD devices, documenting occlusion outcomes using the O'Kelly-Marotta and modified Cekirge-Saatci scales, as well as the safety of FD usage in bifurcation locations.
This retrospective, single-center study analyzed a prospectively maintained database of patients with cerebral aneurysms treated endovascularly. The study identified bifurcation aneurysms that were treated between January 2019 and May 2022 by placing an FD device covering the neck of the aneurysm.
Our short series suggests that flow diversion is a viable therapeutic option for bifurcation aneurysms with favorable angiographic outcomes.
In highly selective cases, flow diversion may be considered for treating bifurcation aneurysms in patients who will undergo follow-up examinations in the future.
Flow diversion has emerged as a valuable technique in the management of bifurcation aneurysms, offering the potential for satisfactory occlusion and long-term outcomes.
血流导向(FD)支架的应用正在不断扩展。动脉分叉处的动脉瘤通常具有不理想的解剖形态,常为宽颈,且包含一条或多条分支动脉。近年来,在治疗颈内动脉以外的颅内动脉瘤时,血流导向的超说明书使用越来越普遍。本研究报告了我们中心使用FD装置治疗分叉动脉瘤的初步经验,使用奥凯利 - 马罗塔(O'Kelly-Marotta)和改良的切基尔盖 - 萨特西(Cekirge-Saatci)量表记录闭塞结果,以及在分叉部位使用FD的安全性。
这项回顾性单中心研究分析了一个前瞻性维护的接受血管内治疗的脑动脉瘤患者数据库。该研究确定了在2019年1月至2022年5月期间通过放置覆盖动脉瘤颈部的FD装置治疗的分叉动脉瘤。
我们的简短系列研究表明,血流导向对于分叉动脉瘤是一种可行的治疗选择,血管造影结果良好。
在高度选择性的病例中,对于未来将接受随访检查的患者,可考虑采用血流导向治疗分叉动脉瘤。
血流导向已成为治疗分叉动脉瘤的一项有价值的技术,具有实现满意闭塞和长期预后的潜力。